| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
B and Proinflammatory Cytokine Expression during Metastatic Tumor Progression of Murine Squamous Cell Carcinoma1
Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland 20892-1419
We reported previously that tumor cells isolated from metastases of the in vitro transformed squamous cell carcinoma line Pam 212 exhibit an elevation in constitutive production of proinflammatory cytokines interleukin (IL)-1
, IL-6, granulocyte-macrophage colony-stimulating factor, and KC (the murine homologue of chemokine Gro-). The basis for constitutive expression of these cytokines after tumor progression in vivo is unknown. Regulation of the expression of these proinflammatory cytokines involves transcription factor nuclear factor 
B (NF-B), which can be activated by cytokines such as tumor necrosis factor (TNF)-. In this study, we compared the constitutive and TNF--induced expression of proinflammatory cytokines in parental Pam 212 and metastatic LY-2 and LY-8 cell lines and determined the relationship of cytokine expression to activation of NF-B. We found that the metastatic cell lines exhibited an increase in constitutive and TNF--inducible expression of proinflammatory cytokines when compared with parental Pam 212 cells. The increased cytokine expression was associated with an increase in constitutive and TNF--inducible activation of NF-B as demonstrated by electrophoretic mobility shift assay and luciferase-reporter gene assay. Constitutive nuclear localization of NF-B p65 was observed in LY-2 and LY-8 cells in culture and in tumor specimens but rarely in Pam 212 cells, consistent with the constitutive activation of NF-B in tumor cells after selection in vivo. Induction of NF-B by TNF- was inhibited by the addition of protease inhibitors calpain inhibitor I and N-tosyl-phechloromethyl ketone and antioxidant 1-pyrrolidinecarbodithioic acid, whereas constitutive activation of NF-B and cytokine KC mRNA expression was inhibited by N-tosyl-phechloromethyl ketone alone. Overexpression of a human IB dominant suppresser in Pam 212 cells inhibited TNF--induced NF-B binding activity and KC expression. These data indicate that activation of NF-B contributes to increased expression of proinflammatory cytokines during metastatic tumor progression of squamous cell carcinoma, and that distinct mechanisms may be involved in the regulation of constitutive and TNF--induced activation of NF-B in squamous cell carcinoma.
This article has been cited by other articles:
|
|
 |
|
  A. O. Rehman and C.-Y. Wang SDF-1{alpha} Promotes Invasion of Head and Neck Squamous Cell Carcinoma by Activating NF-{kappa}B J. Biol. Chem., July 18, 2008; 283(29): 19888 - 19894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Allen, K. Saigal, L. Nottingham, P. Arun, Z. Chen, and C. Van Waes Bortezomib-Induced Apoptosis with Limited Clinical Response Is Accompanied by Inhibition of Canonical but not Alternative Nuclear Factor-{kappa}B Subunits in Head and Neck Cancer Clin. Cancer Res., July 1, 2008; 14(13): 4175 - 4185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Guruvayoorappan and G. Kuttan Biophytum sensitivum (L.) DC Inhibits Tumor Cell Invasion and Metastasis Through a Mechanism Involving Regulation of MMPs, Prolyl Hydroxylase, Lysyl Oxidase, nm23, ERK-1, ERK-2, STAT-1, and Proinflammatory Cytokine Gene Expression in Metastatic Lung Tissue Integr Cancer Ther, March 1, 2008; 7(1): 42 - 50. [Abstract] [PDF]
|
|
|
|
 |
|
 G. T. Stathopoulos, T. P. Sherrill, W. Han, R. T. Sadikot, F. E. Yull, T. S. Blackwell, and B. Fingleton Host Nuclear Factor-{kappa}B Activation Potentiates Lung Cancer Metastasis Mol. Cancer Res., March 1, 2008; 6(3): 364 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Braunstein, S. C. Formenti, and R. J. Schneider Acquisition of Stable Inducible Up-Regulation of Nuclear Factor-{kappa}B by Tumor Necrosis Factor Exposure Confers Increased Radiation Resistance without Increased Transformation in Breast Cancer Cells Mol. Cancer Res., January 1, 2008; 6(1): 78 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.-R. Hahm and S. V. Singh Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity Mol. Cancer Ther., October 1, 2007; 6(10): 2686 - 2695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Lee, X. P. Yang, B. Yan, J. Friedman, P. Duggal, L. Bagain, G. Dong, N. T. Yeh, J. Wang, J. Zhou, et al. A Novel Nuclear Factor-{kappa}B Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status Clin. Cancer Res., October 1, 2007; 13(19): 5680 - 5691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Van Waes, M. Yu, L. Nottingham, and M. Karin Inhibitor-{kappa}B Kinase in Tumor Promotion and Suppression During Progression of Squamous Cell Carcinoma Clin. Cancer Res., September 1, 2007; 13(17): 4956 - 4959. [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Singh, S. Choi, Y. Zeng, E.-R. Hahm, and D. Xiao Guggulsterone-Induced Apoptosis in Human Prostate Cancer Cells Is Caused by Reactive Oxygen Intermediate Dependent Activation of c-Jun NH2-Terminal Kinase Cancer Res., August 1, 2007; 67(15): 7439 - 7449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Guruvayoorappan and G. Kuttan Effect of Amentoflavone on the Inhibition of Pulmonary Metastasis Induced by B16F-10 Melanoma Cells in C57BL/6 Mice Integr Cancer Ther, June 1, 2007; 6(2): 185 - 197. [Abstract] [PDF]
|
|
|
|
|
|
C. Van Waes Nuclear Factor-{kappa}B in Development, Prevention, and Therapy of Cancer Clin. Cancer Res., February 15, 2007; 13(4): 1076 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yu, J. Yeh, and C. Van Waes Protein Kinase Casein Kinase 2 Mediates Inhibitor-{kappa}B Kinase and Aberrant Nuclear Factor-{kappa}B Activation by Serum Factor(s) in Head and Neck Squamous Carcinoma Cells. Cancer Res., July 1, 2006; 66(13): 6722 - 6731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. Stathopoulos, Z. Zhu, M. B. Everhart, I. Kalomenidis, W. E. Lawson, S. Bilaceroglu, T. E. Peterson, D. Mitchell, F. E. Yull, R. W. Light, et al. Nuclear Factor-{kappa}B Affects Tumor Progression in a Mouse Model of Malignant Pleural Effusion Am. J. Respir. Cell Mol. Biol., February 1, 2006; 34(2): 142 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Singh, Y. Zeng, D. Xiao, V. G. Vogel, J. B. Nelson, R. Dhir, and Y. B. Tripathi Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak Mol. Cancer Ther., November 1, 2005; 4(11): 1747 - 1754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jorda, D. Olmeda, A. Vinyals, E. Valero, E. Cubillo, A. Llorens, A. Cano, and A. Fabra Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor J. Cell Sci., August 1, 2005; 118(15): 3371 - 3385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Alvarez, F. Prada, E. Salvatierra, A. I. Bravo, V. P. Lutzky, C. Carbone, F. J. Pitossi, H. E. Chuluyan, and O. L. Podhajcer Secreted Protein Acidic and Rich in Cysteine Produced by Human Melanoma Cells Modulates Polymorphonuclear Leukocyte Recruitment and Antitumor Cytotoxic Capacity Cancer Res., June 15, 2005; 65(12): 5123 - 5132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kan, Y. Shimada, F. Sato, T. Ito, K. Kondo, G. Watanabe, M. Maeda, S. Yamasaki, S. J. Meltzer, and M. Imamura Prediction of Lymph Node Metastasis with Use of Artificial Neural Networks Based on Gene Expression Profiles in Esophageal Squamous Cell Carcinoma Ann. Surg. Oncol., December 1, 2004; 11(12): 1070 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Loercher, T. L. Lee, J. L. Ricker, A. Howard, J. Geoghegen, Z. Chen, J. B. Sunwoo, R. Sitcheran, E. Y. Chuang, J. B. Mitchell, et al. Nuclear Factor-{kappa}B is an Important Modulator of the Altered Gene Expression Profile and Malignant Phenotype in Squamous Cell Carcinoma Cancer Res., September 15, 2004; 64(18): 6511 - 6523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. P. Veiby and M. A. Read Chemoresistance: Impact of Nuclear Factor (NF)-{kappa}B Inhibition by Small Interfering RNA: Commentary re J. Guo et al., Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the NF-{kappa}B p65 Subunit. Clin Cancer Res 2004;10:3333-3341 Clin. Cancer Res., May 15, 2004; 10(10): 3262 - 3264. [Full Text] [PDF]
|
|
|
|
|
|
M. Benezra, N. Chevallier, D. J. Morrison, T. K. MacLachlan, W. S. El-Deiry, and J. D. Licht BRCA1 Augments Transcription by the NF-{kappa}B Transcription Factor by Binding to the Rel Domain of the p65/RelA Subunit J. Biol. Chem., July 11, 2003; 278(29): 26333 - 26341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Helbig, K. W. Christopherson II, P. Bhat-Nakshatri, S. Kumar, H. Kishimoto, K. D. Miller, H. E. Broxmeyer, and H. Nakshatri NF-{kappa} B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4 J. Biol. Chem., June 6, 2003; 278(24): 21631 - 21638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Hodge, J. Bub, S. Kaul, A. Kajdacsy-Balla, and P. F. Lindholm Requirement of RhoA Activity for Increased Nuclear Factor {kappa}B Activity and PC-3 Human Prostate Cancer Cell Invasion Cancer Res., March 15, 2003; 63(6): 1359 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Wang, B. J. Manning, Q. D. Wu, S. Blankson, D. Bouchier-Hayes, and H. P. Redmond Endotoxin/Lipopolysaccharide Activates NF-{kappa}B and Enhances Tumor Cell Adhesion and Invasion Through a {beta}1 Integrin-Dependent Mechanism J. Immunol., January 15, 2003; 170(2): 795 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-H. Shen, J.-H. Zhou, S. R. Broussard, G. G. Freund, R. Dantzer, and K. W. Kelley Proinflammatory Cytokines Block Growth of Breast Cancer Cells by Impairing Signals from a Growth Factor Receptor Cancer Res., August 15, 2002; 62(16): 4746 - 4756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Wolf, Z. Chen, G. Dong, J. B. Sunwoo, C. C. Bancroft, D. E. Capo, N. T. Yeh, N. Mukaida, and C. V. Waes IL (Interleukin)-1{{alpha}} Promotes Nuclear Factor-{{kappa}}B and AP-1-induced IL-8 Expression, Cell Survival, and Proliferation in Head and Neck Squamous Cell Carcinomas Clin. Cancer Res., June 1, 2001; 7(6): 1812 - 1820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Sunwoo, Z. Chen, G. Dong, N. Yeh, C. C. Bancroft, E. Sausville, J. Adams, P. Elliott, and C. Van Waes Novel Proteasome Inhibitor PS-341 Inhibits Activation of Nuclear Factor-{{kappa}}B, Cell Survival, Tumor Growth, and Angiogenesis in Squamous Cell Carcinoma Clin. Cancer Res., May 1, 2001; 7(5): 1419 - 1428. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. S. Brar, T. P. Kennedy, A. R. Whorton, A. B. Sturrock, T. P. Huecksteadt, A. J. Ghio, and J. R. Hoidal Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-{kappa}B in malignant melanoma cells Am J Physiol Cell Physiol, March 1, 2001; 280(3): C659 - C676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. B. Andela, E. M. Schwarz, J. E. Puzas, R. J. O’Keefe, and R. N. Rosier Tumor Metastasis and the Reciprocal Regulation of Prometastatic and Antimetastatic Factors by Nuclear Factor {{kappa}}B Cancer Res., December 1, 2000; 60(23): 6557 - 6562. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. E. Kupferman, M. E. Fini, W. J. Muller, R. Weber, Y. Cheng, and R. J. Muschel Matrix Metalloproteinase 9 Promoter Activity Is Induced Coincident with Invasion during Tumor Progression Am. J. Pathol., December 1, 2000; 157(6): 1777 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. HONG, F. G. ONDREY, I. M. AVIS, Z. CHEN, E. LOUKINOVA, P. F. CAVANAUGH JR, C. VAN WAES, and J. L. MULSHINE Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation? FASEB J, August 1, 2000; 14(11): 1499 - 1507. [Abstract] [Full Text]
|
|
|
|
|
|
M. Holmes-McNary and A. S. Baldwin Jr. Chemopreventive Properties of trans-Resveratrol Are Associated with Inhibition of Activation of the I{{kappa}}B Kinase Cancer Res., July 1, 2000; 60(13): 3477 - 3483. [Abstract] [Full Text]
|
|
|
|
|
|
S. K. Manna, N. K. Sah, R. A. Newman, A. Cisneros, and B. B. Aggarwal Oleandrin Suppresses Activation of Nuclear Transcription Factor-{{kappa}}B, Activator Protein-1, and c-Jun NH2-Terminal Kinase Cancer Res., July 1, 2000; 60(14): 3838 - 3847. [Abstract] [Full Text]
|
|
|
|
|
|
S. Huang, A. DeGuzman, C. D. Bucana, and I. J. Fidler Nuclear Factor-{{kappa}}B Activity Correlates with Growth, Angiogenesis, and Metastasis of Human Melanoma Cells in Nude Mice Clin. Cancer Res., June 1, 2000; 6(6): 2573 - 2581. [Abstract] [Full Text]
|
|
|
|
|
|
D. Wang and A. Richmond Nuclear Factor-kappa B Activation by the CXC Chemokine Melanoma Growth-stimulatory Activity/Growth-regulated Protein Involves the MEKK1/p38 Mitogen-activated Protein Kinase Pathway J. Biol. Chem., January 26, 2001; 276(5): 3650 - 3659. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
